Correction: Taha et al. Assessing Bacterial Viability and Label Accuracy in Human and Poultry Probiotics Sold in the United Kingdom. Microorganisms 2025, 13, 1933
| Product Code | Species Declared on the Label | Declared Label Total (CFU/g) | MALDI-TOF MS ID 2 | Observed Viable Plate Counts (Mean ± SD) 3 |
|---|---|---|---|---|
| P3 | Bacillus subtilis | 2.5 × 107 | Bacillus spp. | 1.375 × 107 ± 2.06 × 106 |
| P4 | Bacillus subtilis | 3 × 108 | Bacillus spp. | 1.900 × 108 ± 1.82 × 107 |
| P5 | Bacillus subtilis | 2 × 109 | Bacillus spp. | 1.400 × 1010 ± 2.58 × 109 |
| P9 | Bifidobacterium animalis | Ratio 1 3/10 | Bifidobacterium animalis | 1.300 × 108 ± 2.58 × 107 |
| Lactobacillus salivarius | Ratio 1/10 | Ligilactobacillus salivarius | 3.200 × 107 ± 3.65 × 106 | |
| Enterococcus faecium | Ratio 6/10 | Enterococcus faecium | 1.055 × 109 ± 4.43 × 107 | |
| Total bacteria | 1 × 109 | Total bacteria | 1.212 × 109 ± 4.47 × 107 | |
| P10 | Enterococcus faecium | 2 × 1010 | Enterococcus faecium | 5.800 × 1010 ± 4.54 × 109 |
| P11 | Bacillus subtilis | 2 × 108 | Bacillus spp. | 5.950 × 108 ± 3.10 × 107 |
| P12 | Bifidobacterium animalis | Ratio 1 3/10 | Bifidobacterium animalis | 1.080 × 107 ± 1.48 × 106 |
| Lactobacillus salivarius | Ratio 1/10 | Ligilactobacillus salivarius | 1.375 × 106 ± 2.21 × 105 | |
| Enterococcus faecium | Ratio 6/10 | Enterococcus faecium | 5.300 × 108 ± 4.32 × 107 | |
| Total bacteria | 2 × 108 | Total bacteria | 5.418 × 108 ± 4.22 × 107 |
| Product Code | Form | Species Declared on the Label | Declared Label Total (CFU/Form 1) | MALDI-TOF MS ID 3 | Observed Viable Plate Counts (Mean ± SD) 4 |
|---|---|---|---|---|---|
| P1 | Tablets | Lactobacillus acidophilus | 2 × 1011 | NA | No CFU detected 2 |
| P2 | Capsule | Lactobacillus acidophilus | ND 5 | Lactobacillus acidophilus | 3.483 × 109 ± 2.76 × 108 |
| Bifidobacterium animalis | ND | Bifidobacterium animalis | 6.533 × 108 ± 3.51 × 107 | ||
| Bifidobacterium bifidum | ND | ||||
| Total bacteria | 1 × 1010 | Total bacteria | 4.137 × 109 ± 2.96 × 108 | ||
| P6 | Capsules | Lactobacillus acidophilus | ND | Lactobacillus acidophilus | 3.300 × 109 ± 1.00 × 108 |
| Lactobacillus salivarius | ND | Lactobacillus salivarius | 2.067 × 106 ± 4.61 × 105 | ||
| Bifidobacterium animalis | ND | Bifidobacterium animalis | 2.100 × 107 ± 2.00 × 106 | ||
| Lactobacillus Bulgaricus | ND | ||||
| Total bacteria | 3 × 109 | Total bacteria | 3.320 × 109 ± 1.01 × 108 | ||
| P7 | Capsules | Lactobacillus acidophilus | ND | Lactobacillus acidophilus | 5.667 × 109 ± 3.05 × 108 |
| Bifidobacterium bifidum | ND | Bifidobacterium bifidum | 8.100 × 108 ± 4.35 × 107 | ||
| Total bacteria | 1 × 1010 | Total bacteria | 6.477 × 109 ± 3.36 × 108 | ||
| P8 | Chewable Tablets | Lactobacillus acidophilus | ND | Lactobacillus acidophilus | 5.533 × 108 ± 1.52 × 107 |
| Bifidobacterium animalis | ND | Bifidobacterium animalis | 2.800 × 107 ± 1.00 × 106 | ||
| Total bacteria | 1 × 109 | Total bacteria | 5.813 × 108 ± 1.56 × 107 |
Reference
- Taha, M.W.; Fenwick, D.J.C.; Marrs, E.C.L.; Chaudhry, A.S. Assessing Bacterial Viability and Label Accuracy in Human and Poultry Probiotics Sold in the United Kingdom. Microorganisms 2025, 13, 1933. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Share and Cite
Taha, M.W.; Fenwick, D.J.C.; Marrs, E.C.L.; Chaudhry, A.S. Correction: Taha et al. Assessing Bacterial Viability and Label Accuracy in Human and Poultry Probiotics Sold in the United Kingdom. Microorganisms 2025, 13, 1933. Microorganisms 2026, 14, 607. https://doi.org/10.3390/microorganisms14030607
Taha MW, Fenwick DJC, Marrs ECL, Chaudhry AS. Correction: Taha et al. Assessing Bacterial Viability and Label Accuracy in Human and Poultry Probiotics Sold in the United Kingdom. Microorganisms 2025, 13, 1933. Microorganisms. 2026; 14(3):607. https://doi.org/10.3390/microorganisms14030607
Chicago/Turabian StyleTaha, Mostafa Waleed, Danielle J. C. Fenwick, Emma C. L. Marrs, and Abdul Shakoor Chaudhry. 2026. "Correction: Taha et al. Assessing Bacterial Viability and Label Accuracy in Human and Poultry Probiotics Sold in the United Kingdom. Microorganisms 2025, 13, 1933" Microorganisms 14, no. 3: 607. https://doi.org/10.3390/microorganisms14030607
APA StyleTaha, M. W., Fenwick, D. J. C., Marrs, E. C. L., & Chaudhry, A. S. (2026). Correction: Taha et al. Assessing Bacterial Viability and Label Accuracy in Human and Poultry Probiotics Sold in the United Kingdom. Microorganisms 2025, 13, 1933. Microorganisms, 14(3), 607. https://doi.org/10.3390/microorganisms14030607

